21 Sep 22
Dr Muhunthan Thillai CEO said "We are really excited that Dr Fernandez has joined us to assist the company with our data strategy as we expand operations. Xose brings over 25 years’ experience...
15 Sep 22
Qureight has met the requirements to use our quality management system for the design of medical devices. We are pleased as it shows our dedication to maintaining a high quality QMS as we continue to develop our platform.
23 Aug 22
Qureight today announces its Scientific Advisory Board for Idiopathic Pulmonary Fibrosis (IPF). This progressive scarring lung disease is one of the company’s three benchmark conditions alongside...
18 Feb 21
Study aims to investigate correlations between image and serum collagen biomarkers to advance the clinical measurement of progression in fibrotic lung diseases.
18 Jan 21
Darren brings 20 years of big data platform engineering experience as Qureight builds out its senior team post pre-seed investment.
If you would like to find out more about our company and our technology please get in touch.